In Cloning, Will One Person Really Make a Difference?

In just a week, two developments in Washington restored cloning to the very top of the policy agenda in the United States, knocking stem cell research off the perch it had enjoyed--or just endured--for months. On July 31, by a vote of 265 to 162, the House of Representatives passed the Human Cloning Prohibition Act of 2001, a ban on all human cloning, including therapeutic cloning to derive immunologically compatible embryonic stem cells. And on August 7, Severino Antinori, an infertility specia

Written byArlene Judith Klotzko
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

According to reports, eight of the women who have sought out Antinori are from the United Kingdom. In Britain, reproductive cloning will be made illegal when legislation is introduced by the government in the next Parliament. Meanwhile, the Human Fertilisation and Embryology Authority, which licenses embryo research and storage and infertility treatment involving donated gametes, has announced that it would refuse to license any attempt at reproductive cloning. Hence the necessity for an airplane ticket.

Is there anything that can be done about this reproductive tourism? The British Royal Society has called for a worldwide moratorium on reproductive cloning, at least until the risks and possible justifications of the technique are explored fully. But the obstacles in the way of achieving such a moratorium are daunting and most likely insurmountable. There have been rumors that some unnamed Mediterranean country--clearly not his own--has agreed to host Antinori's efforts. And there have ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies